Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on May 20, 2022
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 538 cr
Turnover Ratio
Expense Ratio 1.07%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: -6.67%
  • 1Y: -0.97%
  • 3M: -2.95%
  • 3Y: 24.48%
  • 6M: -6.89%
  • 5Y: 14.00%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since about 1 year)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 28.93
P/B Ratio 4.34
Launch Date December 28, 2015
Benchmark IISL Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs IISL Nifty Pharma TR INR

Alpha 11.17
Beta 0.71
R-Squared 85.66
Info Ratio 1.04
Tracking Err 10.07
Sortino 2.367
Sharpe 1.024
Std Dev 18.616
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.5%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 99.50%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
22.268 0.36% 1,790 cr 0.64% -
17.815 -0.97% 538 cr 1.07% -
231.291 -5.21% 1,763 cr 1.05% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata